Zobrazeno 1 - 10
of 23
pro vyhledávání: '"John S"'
Autor:
John S. Gill
Publikováno v:
Transplantation. 102(3)
Publikováno v:
Transplantation. 89:1057-1070
BACKGROUND.: Polyomavirus-associated nephropathy (PVAN) is an important cause of kidney graft loss but there is no consensus on its management. This study aimed to systematically document all published treatments for PVAN to determine the most effect
Autor:
Mustafa M. Ugurlu, Lisa E. Diamond, Sandra R. Severson, Christopher G.A. McGregor, Gregor Warnecke, Virginia M. Miller, John S. Logan, C.B. Taner
Publikováno v:
Transplantation. 73:1060-1067
Background. Expression of human complement regulating factor (hCRF) in porcine organs prevents hyperacute rejection of these organs after xenotransplantation to nonhuman primates. Experiments were designed to characterize endothelial and smooth muscl
Autor:
John S Bynon, Luc Frenette, Sharon L. Hudson, Brendan M. McGuire, Devin E. Eckhoff, Carlton J. Young, Juan L. Contreras, Marty T. Sellers
Publikováno v:
Transplantation. 69:1867-1872
Background Induction therapy with daclizumab has been shown to be efficacious in the prevention of acute rejection in kidney transplant patients. The routine use of antibody induction therapy in liver transplantation has not gained widespread accepta
Autor:
Ciocci G, John S. Thompson, C Coffey, E H Romond, J S Macdonald, Marciniak E, Henslee-Downey Pj, R S Parrish
Publikováno v:
Transplantation. 61:738-745
Most patients requiring allogeneic bone marrow transplantation (BMT) lack a human leukocyte antigen genotypically identical sibling and require an alternative donor. This carries an increased risk of graft failure and acute graft-versus-host disease
Autor:
David E.R. Sutherland, Arthur J. Matas, John S. Najarian, Kristen J. Gillingham, James V. Harmon, David L. Dunn, Rainer W.G. Gruessner, Ty B. Dunn, Raja Kandaswamy, Khalid Khwaja, Abhinav Humar, Massimo Asolati, William D. Payne, J. Keith Melancon
Publikováno v:
Transplantation. 78:1397-1399
Prednisone-minimization protocols have been successful in low-risk recipients. We report on the use of a protocol incorporating rapid discontinuation of prednisone in a cohort of kidney transplant recipients (n = 79) at increased immunologic risk. Ou
Autor:
Paul F. Gores, Rainer W.G. Gruessner, David E.R. Sutherland, W. J. Schmidt, Arthur J. Matas, John S. Najarian, David L. Dunn, Henry H. Balfour, Kristen J. Gillingham, Marie A. Kramer, William D. Payne, Alejo Erice
Publikováno v:
Transplantation. 57:876-883
Cytomegalovirus disease occurs frequently after solid organ transplantation and has been associated with decreased patient and allograft survival. We hypothesized that CMV transmission or reactivation begins immediately or soon after transplantation,
Autor:
David E.R. Sutherland, William D. Payne, P. Stephen Almond, John S. Najarian, Thomas E. Nevins, Clifford E. Kashtan, Arthur J. Matas, Paul F. Gores, David L. Dunn, Michael Mauer, Kristen J. Gillingham, Adyr A. Moss, Blanche M. Chavers
Publikováno v:
Transplantation. 53:46-51
Cyclosporine has improved the results of renal transplantation. In 1984, we began using it as part of a sequential immunosuppression protocol (MALG, AZA, P, and delayed administration of CsA) in our pediatric renal transplant recipients. We studied t
Autor:
Eva M. Vasquez, John S. Thompson, Raymond Pollak, Dar Shong Hwang, Thomas Waid, Judy Hyun Ju Jin, Mark D. Pescovitz, Donald E. Hricik, Duane G. Wombolt, R. Wong, Timothy L. Pruett, David I. Min, M. Gerry Choc, Gary Barone, James B. Stinson, Christopher L. Marsh, Jon B. Klein
Publikováno v:
Transplantation. 63:778-780
BACKGROUND The new microemulsion formulation of cyclosporine (CsA-ME) is more bioavailable than cyclosporine (CsA) in de novo renal transplant patients. Therefore, it was of interest to compare the safety profile of each formulation in such patients.
Autor:
Johannes Schirmer, John S. Logan, Marian G. Michaels, Christopher G.A. McGregor, Guerard W. Byrne, Henry D. Tazelaar, Randall C. Walker, Jack M. Risdahl, Sumeet S. Teotia
Publikováno v:
Transplantation. 78(11)
Background Animal organs could satisfy the demand for solid organ transplants, which currently exceeds the limited human donor supply. Hyperacute rejection, the initial immune barrier to successful xenotransplantation, has been overcome with pig dono